DTAB Recommends All Antimicrobials Be Treated as New Drugs to Tackle AMR

In a major regulatory move aimed at curbing antimicrobial resistance (AMR), the Drugs Technical Advisory Board (DTAB) has recommended that all antimicrobials should be permanently classified as...

Alembic Pharma Eyes FY26 Growth with Domestic Surge and Global Push

Alembic Pharmaceuticals has raised its expectation margin for FY26, with increased domestic sales, and international expansion. The CFO of the company, R.K.Baheti informed Moneycontrol that the company recorded higher E...

Govt Set to Roll Out Stricter Norms for Biosimilar Approvals

The Indian government is putting final touches on revised regulations to tighten quality requirements for biosimilar medicines, treatments derived from living cells applied in the treatment of cancers and...

Pharma Firm Corona Remedies Files Rs. 800 Crore IPO with SEBI

The Securities and Exchange Board of India (SEBI) is to launch a Rs. 800 crore Initial Public Offering (IPO) with the Draft Red Herring Prospects (DRHP)

Authorities Propose Stricter Control of Tapentadol under Narcotics Act

Tapentadlol is used for patients who have limited substitute treatment options and for pain.

AbbVie Gets FDA Nod for Rinvoq in Treating Giant Cell Arteritis

A daily dose of Rinvoq (upadacitinib) 15 mg from AbbVie now receives FDA approval for treating severe autoimmune condition Giant Cell Arteritis (GCA) despite the lack of a cure while the disease progresses to threaten vision along with stroke and aor

AITUC Accuses Govt, Pharma Companies of Neglecting Worker Rights on Labour Day

At a rally in Panaji, Goa today, on International Labour Day, Suhas Naik, the All India Trade Union Congress secretary.

Piyush Goyal Takes Critical Stance against Evergreening of Patients

In the World Health Summit (WHS) Regional Meeting Asia 2025, Piyush Goyal, Minister of Commerce & Industry criticized pharmaceutical companies for making their patent evergreen. The summit was held in Delhi’s Bharat Manda...

New Tariffs on Imported Drugs under Trump's Plan May Trigger Price Surge & Supply Gaps

Prescription drugs that are often made or contain ingredients from China and India are stocked up in American households.

Integrated Pharma Firm Syngene Hits Rs. 496.2 Crore Profit

Syngene International has made a report stating that it has earned a total income of Rs.1036.9 for the period ended March 31, 2025. Leading to the company making a net profit of 183.3 crores for the same period. The company's financial year 20...